SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Koopman Miriam)
 

Sökning: WFRF:(Koopman Miriam) > European practice p...

  • Derksen, Jeroen W. G.Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands.;Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands. (författare)

European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • Elsevier,2020
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-423452
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423452URI
  • https://doi.org/10.1016/j.ejca.2020.07.020DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background: Smoking cessation after a cancer diagnosis is associated with improved overall survival. Few studies have reported oncologists' cessation practice patterns, but differences between the curative and palliative settings have not been described. We aimed to study the oncologist's perceptions on patients' tobacco use, current practices and barriers to providing smoking cessation support, while distinguishing between treatment with curative (C) and palliative (P) intent.Methods: In 2019, an online 34-item survey was sent to approximately 6235 oncologists from 16 European countries. Responses were descriptively reported and compared by treatment setting.Results: Responses from 544 oncologists were included. Oncologists appeared to favour addressing tobacco in the curative setting more than in the palliative setting. Oncologists believe that continued smoking impacts treatment outcomes (C: 94%, P: 74%) and that cessation support should be standard cancer care (C: 95%, P: 63%). Most routinely assess tobacco use (C: 93%, P: 78%) and advise patients to stop using tobacco (C: 88%, P: 54%), but only 24% (P)–39% (C) routinely discuss medication options, and only 18% (P)–31% (C) provide cessation support. Hesitation to remove a pleasurable habit (C: 13%, P: 43%) and disbelieve on smoking affecting outcomes (C: 3%, P: 14%) were disparate barriers between the curative and palliative settings (p < 0.001), but dominant barriers of time, resources, education and patient resistance were similar between settings.Conclusion: Oncologists appear to favour addressing tobacco use more in the curative setting; however, they discuss medication options and/or provide cessation support in a minority of cases. All patients who report current smoking should have access to evidence-based smoking cessation support, also patients treated with palliative intent given their increasing survival.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Warren, Graham W.Med Univ South Carolina, Dept Radiat Oncol, Charleston, SC 29425 USA. (författare)
  • Jordan, KarinUniv Hosp Heidelberg, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany. (författare)
  • Rauh, StefanCtr Hosp Emile Mayrisch, Dept Oncol, Esch Sur Alzette, Luxembourg. (författare)
  • Vera Garcia, RuthComplejo Hosp Navarra, Dept Med Oncol, Pamplona, Spain. (författare)
  • O'Mahony, DeirdreCork Univ Hosp, Dept Med Oncol, Cork, Ireland. (författare)
  • Ahmed, SamreenUniv Hosp Leicester, Dept Med Oncol, Leicester, Leics, England. (författare)
  • Vuylsteke, PeterUCLouvain, CHU Namur, Dept Med Oncol, Namur, Belgium.;Univ Botswana, Fac Med, Gaborone, Botswana. (författare)
  • Radulovic, SinisaInst Oncol & Radiol Serbia, Dept Expt Oncol, Belgrade, Serbia. (författare)
  • Tsoukalas, Nikolaos401 Gen Mil Hosp Athens, Dept Oncol, Athens, Greece. (författare)
  • Wysocki, Piotr J.Jagiellonian Univ, Dept Oncol, Med Coll, Krakow, Poland. (författare)
  • Borner, MarkusUniv Hosp Basel, Dept Med Oncol, Basel, Switzerland. (författare)
  • Cesas, AlvydasKlaipeda Univ Hosp, Dept Med Oncol, Klaipeda, Lithuania. (författare)
  • Elme, AnneliNorth Estonia Med Ctr Fdn, Dept Oncol & Hematol, Tallinn, Estonia. (författare)
  • Minn, HeikkiTurku Univ Hosp, Dept Oncol, Turku, Finland. (författare)
  • Ullenhag, Gustav J.Uppsala universitet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab(Swepub:uu)gustulle (författare)
  • Roodhart, Jeanine M. L.Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands. (författare)
  • Koopman, MiriamUniv Utrecht, Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands. (författare)
  • May, Anne M.Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands. (författare)
  • Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands.;Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.Med Univ South Carolina, Dept Radiat Oncol, Charleston, SC 29425 USA. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:European Journal of Cancer: Elsevier138, s. 99-1080959-80491879-0852

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy